Form 4 for ORIC Oric Pharmaceuticals, Inc.

Accepted 2022-05-13 00:00:00 ET · period of report 2022-05-11 · accession 0001209191-22-028963 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-05-13	2022-05-11+	ORIC	Chacko Jacob	Pres, CEO, Dir	P - Purchase	$2.86	+450.0K	726.6K	+163%	+$1.29M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-11	P	A	304,574	$2.90	657,226	D	—	—	(F1) Represents the weighted average share price of an aggregate total of 304,574 shares purchased in the price range of $2.695 to $2.95 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
2	Common	Common Stock	2022-05-13	P	A	76,072	$2.82	802,652	D	—	—	(F3) Represents the weighted average share price of an aggregate total of 76,072 shares purchased in the price range of $2.79 to $2.93 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
3	Common	Common Stock	2022-05-12	P	A	69,354	$2.75	726,580	D	—	—	(F2) Represents the weighted average share price of an aggregate total of 69,354 shares purchased in the price range of $2.70 to $2.77 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.